Showing results (1671-1680 of 1,961) with videos related to

Sort By:
Pageof 197
Biochemical and Biophysical Research Communications|May 4, 2004
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activitiesThomas W Doebber, Linda J Kelly, Gaochao Zhou, et al.
Diabetes Care|December 19, 2015
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 StudiesChristof M Kazda, Ying Ding, Ronan P Kelly, et al.
Tissue Engineering. Part A|January 6, 2015
Crosslinkable hydrogels derived from cartilage, meniscus, and tendon tissueJetze Visser, Peter A Levett, Nikae C R te Moller, et al.
Neuro-Oncology Advances|September 22, 2025
A randomized controlled trial of a telehealth group cognitive intervention (LaTCH-BRAINS) to improve cognition after primary brain tumor diagnosisKerryn E Pike, Sian E B Virtue-Griffiths, Rachel Campbell, et al.
Nature Communications|May 18, 2026
De novo design of a macrocycle-induced dimerization system for cellular controlStephanie Hanna, Patrick J Salveson, Basile Wicky, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
De novo design of a macrocycle induced dimerization system for cellular controlStephanie Hanna, Patrick J Salveson, Basile Wicky, et al.
Endocrinology|May 22, 2002
Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonistsDavid L Gerhold, Franklin Liu, Guoqiang Jiang, et al.
Osteoarthritis and Cartilage|December 28, 2020
Machine learning augmented near-infrared spectroscopy: In vivo follow-up of cartilage defectsJ K Sarin, N C R Te Moller, A Mohammadi, et al.
Osteoarthritis and Cartilage|July 6, 2019
T2* and quantitative susceptibility mapping in an equine model of post-traumatic osteoarthritis: assessment of mechanical and structural properties of articular cartilageO Nykänen, J K Sarin, J H Ketola, et al.
Circulation|March 12, 2008
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trialDenis Roy, Craig M Pratt, Christian Torp-Pedersen, et al.
Pageof 197